GSA Capital Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.62M | Sell |
|
|||||
|
2025
Q2 | $2.68M | Buy |
|
|||||
|
2025
Q1 | $372K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $704K | Sell |
|
|||||
|
2023
Q4 | $1.19M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $170K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $170K | Sell |
|
|||||
|
2022
Q2 | $691K | Buy |
|
|||||
|
2022
Q1 | $482K | Buy |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $745K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $548K | Buy |
|
|||||
|
2019
Q1 | $153K | Sell |
|
|||||
|
2018
Q4 | $376K | Sell |
|
|||||
|
2018
Q3 | $796K | Buy |
|
|||||
|
2018
Q2 | $212K | Sell |
|
|||||
|
2018
Q1 | $431K | Sell |
|
|||||
|
2017
Q4 | $732K | Buy |
|
|||||
|
2017
Q3 | $624K | Buy |
|
|||||
|
2017
Q2 | $324K | Sell |
|
|||||
|
2017
Q1 | $1.32M | Sell |
|
|||||
|
2016
Q4 | $2.01M | Buy |
|
|||||
|
2016
Q3 | $1.64M | Sell |
|
|||||
|
2016
Q2 | $1.49M | Buy |
|
|||||
|
2016
Q1 | $745K | Buy |
|